Ke‐Wu Yang

2.1k total citations
98 papers, 1.8k citations indexed

About

Ke‐Wu Yang is a scholar working on Molecular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Ke‐Wu Yang has authored 98 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Medicine, 27 papers in Molecular Biology and 23 papers in Epidemiology. Recurrent topics in Ke‐Wu Yang's work include Antibiotic Resistance in Bacteria (61 papers), Pneumocystis jirovecii pneumonia detection and treatment (23 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). Ke‐Wu Yang is often cited by papers focused on Antibiotic Resistance in Bacteria (61 papers), Pneumocystis jirovecii pneumonia detection and treatment (23 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). Ke‐Wu Yang collaborates with scholars based in China, United States and United Kingdom. Ke‐Wu Yang's co-authors include Michael W. Crowder, Peter Oelschlaeger, Le Zhai, Le-Yun Sun, Brian Bennett, Cheng Chen, Cheng Chen, Jiaqi Li, Yilin Zhang and Narayan Prasad Sharma and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

Ke‐Wu Yang

96 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke‐Wu Yang China 26 807 426 403 337 287 98 1.8k
Christian Damblon Belgium 28 849 1.1× 673 1.6× 211 0.5× 227 0.7× 357 1.2× 56 1.7k
Bala Kishan Gorityala Singapore 20 409 0.5× 554 1.3× 620 1.5× 151 0.4× 265 0.9× 27 1.4k
Rubén H. Manzo Argentina 31 317 0.4× 505 1.2× 638 1.6× 80 0.2× 259 0.9× 107 2.7k
Manuela Benvenuti Italy 18 766 0.9× 393 0.9× 103 0.3× 130 0.4× 413 1.4× 37 1.3k
Venkateswarlu Yarlagadda India 20 350 0.4× 765 1.8× 817 2.0× 264 0.8× 211 0.7× 27 1.7k
Padma V. Devarajan India 31 351 0.4× 1.0k 2.4× 273 0.7× 174 0.5× 163 0.6× 91 3.0k
Runming Wang China 24 200 0.2× 426 1.0× 295 0.7× 142 0.4× 78 0.3× 41 2.0k
Cristina Prudêncio Portugal 23 258 0.3× 487 1.1× 867 2.2× 63 0.2× 129 0.4× 59 2.3k
Ning Sun China 28 207 0.3× 967 2.3× 561 1.4× 210 0.6× 147 0.5× 104 2.6k
Feng‐Ling Yang China 29 292 0.4× 547 1.3× 230 0.6× 62 0.2× 143 0.5× 101 2.1k

Countries citing papers authored by Ke‐Wu Yang

Since Specialization
Citations

This map shows the geographic impact of Ke‐Wu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke‐Wu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke‐Wu Yang more than expected).

Fields of papers citing papers by Ke‐Wu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke‐Wu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke‐Wu Yang. The network helps show where Ke‐Wu Yang may publish in the future.

Co-authorship network of co-authors of Ke‐Wu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ke‐Wu Yang. A scholar is included among the top collaborators of Ke‐Wu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke‐Wu Yang. Ke‐Wu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Cheng, Peter Oelschlaeger, Jürgen Brem, et al.. (2023). A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases. Chemical Communications. 59(60). 9227–9230. 2 indexed citations
3.
Yang, Ke‐Wu, Ke Wang, Xianfeng Shen, et al.. (2023). Ceria crystal facet impact for methane C–H activation in Pd/CeO2 catalysts. Catalysis Science & Technology. 13(15). 4489–4497. 2 indexed citations
4.
Chen, Cheng, Peter Oelschlaeger, Dongmei Wang, et al.. (2022). Structure and Mechanism-Guided Design of Dual Serine/Metallo-Carbapenemase Inhibitors. Journal of Medicinal Chemistry. 65(8). 5954–5974. 13 indexed citations
5.
Sun, Le-Yun, Cheng Chen, Jiaqi Li, et al.. (2021). Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals. Bioorganic Chemistry. 112. 104889–104889. 54 indexed citations
6.
Li, Jiaqi, Le Zhai, Le-Yun Sun, et al.. (2021). Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases. Bioorganic & Medicinal Chemistry. 38. 116128–116128. 14 indexed citations
7.
Yang, Xiang, Yuejuan Zhang, Ying Ge, et al.. (2020). Kinetic, Thermodynamic, and Crystallographic Studies of 2-Triazolylthioacetamides as Verona Integron-Encoded Metallo-β-Lactamase 2 (VIM-2) Inhibitor. Biomolecules. 10(1). 72–72. 6 indexed citations
8.
Li, Jiaqi, et al.. (2020). Hydroxamic acid with benzenesulfonamide: An effective scaffold for the development of broad-spectrum metallo-β-lactamase inhibitors. Bioorganic Chemistry. 105. 104436–104436. 6 indexed citations
9.
Li, Jiaqi, Le-Yun Sun, Zhihui Jiang, et al.. (2020). Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors. Bioorganic Chemistry. 107. 104576–104576. 20 indexed citations
10.
Lv, Miao, Yuejuan Zhang, Fan Zhou, et al.. (2019). Real-time monitoring of D-Ala-D-Ala dipeptidase activity of VanX in living bacteria by isothermal titration calorimetry. Analytical Biochemistry. 578. 29–35. 8 indexed citations
11.
Liu, Jiayun, et al.. (2018). Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo. Bioorganic Chemistry. 84. 192–201. 24 indexed citations
12.
Liu, Xiaolong, Ke‐Wu Yang, Yuejuan Zhang, et al.. (2016). Optimization of amino acid thioesters as inhibitors of metallo-β-lactamase L1. Bioorganic & Medicinal Chemistry Letters. 26(19). 4698–4701. 16 indexed citations
13.
Yang, Ke‐Wu, et al.. (2014). Diaryl‐Substituted Azolylthioacetamides: Inhibitor Discovery of New Delhi Metallo‐β‐Lactamase‐1 (NDM‐1). ChemMedChem. 9(11). 2445–2448. 58 indexed citations
14.
Feng, Lei, Ke‐Wu Yang, Lisheng Zhou, et al.. (2012). N-Heterocyclic dicarboxylic acids: Broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria. Bioorganic & Medicinal Chemistry Letters. 22(16). 5185–5189. 50 indexed citations
15.
Yang, Ke‐Wu, Xu Cheng, Chuan Zhao, et al.. (2011). Synthesis and activity study of phosphonamidate dipeptides as potential inhibitors of VanX. Bioorganic & Medicinal Chemistry Letters. 21(23). 7224–7227. 19 indexed citations
16.
Yang, Ke‐Wu, et al.. (2011). Synthesis, characterization and activity of new phosphonate dipeptides as potential inhibitors of VanX. Bioorganic & Medicinal Chemistry Letters. 22(1). 482–484. 12 indexed citations
17.
Sander, Ian, et al.. (2005). Structural Studies on a Mitochondrial Glyoxalase II. Journal of Biological Chemistry. 280(49). 40668–40675. 77 indexed citations
18.
Yang, Ke‐Wu, Xuanzhen Jiang, & Weichao Zhang. (2004). One-Step Synthesis of n-Butanol from Ethanol Condensation over Alumina-Supported Metal Catalysts. Chinese Chemical Letters. 15(12). 1497–1500. 30 indexed citations
19.
Yang, Ke‐Wu & Michael W. Crowder. (2004). A method for removing ethylenediaminetetraacetic acid from apo-proteins. Analytical Biochemistry. 329(2). 342–344. 3 indexed citations
20.
Crowder, Michael W., et al.. (2001). The problem of a solvent exposable disulfide when preparing Co(II)-substituted metallo-β-lactamase L1 from Stenotrophomonas maltophilia. JBIC Journal of Biological Inorganic Chemistry. 6(1). 91–99. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Damblon Breakdown of academic impact, for papers by Bala Kishan Gorityala Breakdown of academic impact, for papers by Rubén H. Manzo Breakdown of academic impact, for papers by Manuela Benvenuti Breakdown of academic impact, for papers by Venkateswarlu Yarlagadda Breakdown of academic impact, for papers by Padma V. Devarajan Breakdown of academic impact, for papers by Runming Wang Breakdown of academic impact, for papers by Cristina Prudêncio Breakdown of academic impact, for papers by Ning Sun Breakdown of academic impact, for papers by Feng‐Ling Yang
Rankless by CCL
2026